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Abstract 28 
Australian non-users of vitamin supplements (N = 162) and functional foods (N = 29 
226) responded to a questionnaire examining their attitudes, subjective norms, and 30 
perceived behavioural control from the Theory of Planned Behaviour (TPB), risk 31 
dread and risk familiarity, and willingness to engage in free product trials.  The 32 
impact of participants’ gender and age was also examined.  Attitude and subjective 33 
norms were significant determinants of non-users willingness to trial each of the 34 
health products.  Participants’ dread of the risk associated with the product was also a 35 
determinant of willingness to use functional foods.  The overall models predicted 36 
between 25% and 30% of the variance in people’s willingness to trial the products.  37 
The findings provided some support for the TPB in predicting people’s willingness to 38 
trial functional foods and vitamin supplements and suggested, for willingness to trial 39 
functional foods, that non-users are also influenced by their dread of the risk 40 
associated with product use. 41 
 42 
Keywords: attitude, functional foods, vitamin supplements, TPB, risk, willingness, 43 
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Willingness to trial functional foods and vitamin supplements: the role of attitudes, 46 
subjective norms, and dread of risks. 47 
Vitamin supplements and functional foods have a range of applications, 48 
including medicinal, therapeutic, and cosmetic.  These products also have the 49 
potential to provide nutritional benefits to their users.  Certain functional foods and 50 
vitamin supplements have been developed to provide consumers with nutrients that 51 
may be lacking in some people’s diets, or that the body is unable to produce and may 52 
occur in insufficient levels in the food supply.  As identified by previous reviews of 53 
the scientific and commercial development of functional foods (e.g., Tapsell, 2008), 54 
expanding research into social and consumer areas is important to increase the 55 
positive influence of such health products.  Also, to help health practitioners 56 
understand people’s reasons for not using these products, research should examine 57 
groups who do not currently use functional foods or vitamin supplements.  Previous 58 
research has reported that non-users of functional foods cite lack of knowledge, low 59 
perceived importance or interest in functional foods, and price as reasons to not use 60 
the products (Niva, 2006).  Further research into potential consumers’ perceptions of 61 
vitamin supplements and functional foods may assist efforts to encourage some 62 
individuals in the population to use health products appropriately, even if only on a 63 
trial basis, as a potential precursor to more regular use.   64 
Supplements are typically high-potency concentrations of vitamins (or 65 
vitamins and minerals) which are sold separately to the regular food supply, generally 66 
as tablets, liquid or powders (The American Dietetic Association, 2009).  Functional 67 
foods are food items that have been purposefully designed to provide added benefit 68 
beyond normal nutritional value in such a way that it improves health (Urala & 69 
Lähteenmäki, 2003) or reduced disease (Diplock, Aggett, Ashwell, Bornet, Fern, & 70 
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Roberfroid, 1999).   The most widely accepted definition of functional foods includes 71 
the qualification that functional foods are not pills, remain food and are “part of the 72 
normal food pattern” (Diplock, et al, 1999). In the United States of America, the 73 
American Dietetic Association (2009) have acknowledged this distinction between 74 
functional foods and vitamin supplements with functional foods being defined as 75 
enhanced or enriched products that can be used as conventional foods and 76 
supplements a substance ingested to increase intake of a nutrient presented outside the 77 
conventional food of a diet and presented in tablet, powder, or liquid form.   78 
Clear working definitions of vitamin supplements and functional foods are 79 
important to facilitate consumer research, although it is uncertain whether consumers 80 
also make these distinctions.  In an attempt to understand consumer responses to these 81 
products, Cox and Bastiaans (2007) compared consumer preference for vitamin 82 
supplements and foods that are enriched during manufacturing or bio-enriched foods 83 
(pre-manufacturing enrichment, e.g., through animal feed).  Participants indicated that 84 
they would prefer vitamin supplements and bio-enriched foods over foods enriched 85 
during manufacturing but when the method of food enrichment was not specified, 86 
participants were more likely to buy enriched foods and expressed more confidence in 87 
consuming enriched foods compared to supplement products.  Although Cox and 88 
Bastiaans did not examine separately those high and low on intention to use the 89 
products, this finding indicates that, on some level, consumer groups do differentiate 90 
between vitamin supplements and functional foods.  91 
Previous research has examined the cognitive determinants of people’s 92 
openness to consuming vitamin supplements and functional foods.  A positive attitude 93 
about the importance of health has been found to be significant predictor of older 94 
users of vitamin supplements (Sebastian, Cleveland, Goldman, & Moshfegh, 2007) 95 
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and a positive attitude towards functional foods has been reported as a strong 96 
predictor of use (Urala & Lähteenmäki, 2004).  Also, self efficacy (confidence in 97 
one’s ability to perform a behaviour) has been reported as a significant predictor of 98 
people’s acceptance of functional foods in a number of contexts including perceived 99 
importance of consuming of selenium (a mineral connected with disease risk 100 
reduction; Cox & Bastiaans, 2007) and, in a middle-aged sample, people’s intentions 101 
to consume foods enhanced to offset memory loss (Cox, Koster, & Russell, 2004).   102 
One model which incorporates measures of attitude and control (incorporating 103 
the notion of self efficacy), in addition to normative perceptions, as determinates of 104 
people’s behavioural decision-making is the TPB (Ajzen, 1991).  The TPB contends 105 
that people’s behaviour is best predicted by two variables, the intention to perform the 106 
behaviour and the individual’s actual control over performing the behaviour 107 
(Armitage & Conner, 2001).  In turn, intentions are predicted by attitudes, the positive 108 
or negative evaluation of the performance of a behaviour, subjective norms, the 109 
perceived social pressure to perform or not perform a behaviour, and perceived 110 
behavioural control (PBC), an individual’s perception of the degree of control that 111 
they have over the behaviour (Ajzen, 2002).  In addition, attitudes, subjective norms, 112 
and perceived behavioural control are determined by underlying behavioural, 113 
normative, and control beliefs, respectively.  114 
As demonstrated by meta-analyses conducted across a variety of behaviours 115 
(e.g., Armitage & Conner, 2001) and within the health context (e.g., Godin & Kok, 116 
1996), the TPB is established as a valid predictive model of health behaviours.  For 117 
example, the TPB has predicted people’s intentions to engage in healthy eating 118 
(Astrom & Rise, 2001; Guardia, Guerrero, Gelabert, Gou, & Arnau, 2006).  The TPB 119 
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has also been successfully used to predict people’s intentions to consume foods 120 
enriched with Omega-3 fatty acids (Patch, Williams, & Tapsell, 2005). 121 
Although the TPB is traditionally used in the context of people’s intentions to 122 
perform a behaviour, in the current sample of non-users, pre-determined intentions to 123 
use or avoid the health products were expected to be weak.  An alternative outcome 124 
measure used in situations which are unfamiliar or involve spontaneous decisions is 125 
willingness from the Prototype/ Willingness Model (Gibbons & Gerrard, 1995, 1997, 126 
1998).  Previous literature has revealed that willingness is a more suitable outcome 127 
measure than intention when the person is confronted with an unexpected situation 128 
and must make a spontaneous decision (Gibbons & Gerrard, 1995, 1997, 1998), or 129 
when the person has had less experience of the behaviour (Pomery, Gibbons, Reis-130 
Bergan, & Gerrard, 2009).  Willingness does not relate to what a participant intends to 131 
do but rather what they would be willing to do if the situation arose in which there 132 
was the opportunity to perform a behaviour.  As the current study targeted non-users 133 
of the health products, to account for less planned or rational decision making, the 134 
outcome measure adopted in this study was people’s willingness (Gibbons, Gerrard, 135 
Blanton, & Russell, 1998).  136 
Despite the success of the TPB in predicting people’s behaviour in a variety of 137 
contexts, a construct that is not considered explicitly by this model is the 138 
psychological concept of risk and the impact that risk has on decision-making.  For 139 
instance, in the TPB, risk has been considered as a separate element to be added to the 140 
standard TPB predictors (e.g., Bonetti et al., 2006) as well as a factor that is subsumed 141 
in the model’s existing constructs (see, Ajzen, 2002; Hsu & Chiu, 2004).  Given that 142 
previous studies of Australian consumers (FSANZ, 2007) have revealed that moderate 143 
proportions of people have concerns about genetically modified foods (25.3%), and 144 
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functional foods (12.1%), consumer perceptions of risk may be relevant to 145 
understanding people’s willingness to trial functional foods. Previous research also 146 
suggests that the uptake of the newer functional food products involves some degree 147 
of uncertainty (Huotilainen, Prittilä-backman, & Tuorila, 2006).  These findings 148 
indicate that perceptions of risk may influence people’s diet-related decision making.  149 
To determine the underlying factors that contribute to the general public’s 150 
evaluations of technological risk, Slovic and colleagues (Fischhoff, Slovic, 151 
Lichtenstein, Read, & Combs, 1978; Slovic, 1987; Slovic, Fischhoff, & Lichtenstein, 152 
1976) asked participants to evaluate 30 different activities and technologies (including 153 
food colorings and additives) with regard to various risk characteristics such as the 154 
perceived benefits to society, the perceived risks, and the acceptability of current risk 155 
levels.  The underlying factors identified were the participants’ perception of how 156 
devastating the consequences of the risk would be (herein referred to as risk dread) 157 
and knowledge about the risk and the certainty of the consequences versus no 158 
knowledge or understanding of the consequences (herein referred to as risk 159 
familiarity). As functional foods and vitamin supplements may be perceived as food 160 
technologies with similar risks to other forms of technology, these two risk-related 161 
factors, then, will be considered in the present study to assess the additional impact of 162 
these factors after accounting for the standard TPB predictors. 163 
The primary aim of this research was to contribute to the understanding of 164 
potential consumer behaviour by exploring the determinants of non-users’ willingness 165 
to accept a free trial of vitamin supplements or functional foods.  As previous research 166 
suggests that gender and age play a role in decision-making for health products (e.g., 167 
Cox, et al., 2004; Satia-Abouta, Kristal, Patterson, Littman, Stratton, & White, 2003), 168 
these demographic characteristics were considered in the current study.  It was 169 
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expected that the TPB constructs of attitude, subjective norm, and PBC would be 170 
determinants of non-users’ willingness to trial vitamin supplements and functional 171 
foods.  Given that functional foods may be viewed as less established products (e.g., 172 
Huotilainen et al., 2006) with potentially less consumer knowledge and acceptance, it 173 
was expected that the risk measures of dread and familiarity would have more of an 174 
impact on non-users’ willingness to trial functional foods than on their willingness to 175 
trial vitamin supplements.  176 
2. Method 177 
2.1 Participants 178 
A total sample of 271 non-users was recruited as part of a study examining a 179 
number of health products using two methods: an offer of research participation credit 180 
to students enrolled in first year psychology units at a major Australian university (n = 181 
190, age M = 23.68 years, SD = 7.642; 117 females) and a general community sample 182 
(n = 81, age: M = 37.05 years; SD = 13.91; 52 females) gained through a snowballing 183 
effect of friends and colleagues.  Using a Bonferroni adjustment, a series of Analyses 184 
of Variance (ANOVA) confirmed that there were no significant differences between 185 
the two groups on demographic details or on the predictor or the outcome measures.  186 
Further demographic data for the combined sample are presented in Table 1. 187 
[please insert Table 1 about here] 188 
Any participant who qualified to be in both groups (i.e., not using vitamin 189 
supplements or functional foods), was permitted to complete items relating to each 190 
product.  A second series of ANOVA with Bonferroni adjustments indicated that there 191 
were significant differences on the outcome variables between those who were using 192 
one of the products only and were just providing responses of willingness for the 193 
product they had not used, and for those who were non-users for both products 194 
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(vitamin supplements: F (1, 267) = 6.19, p < .05; functional foods: F (1, 267) = 7.36, 195 
p < .01). For each outcome variable, those who already used one of the products were 196 
more likely to be willing to trial the other product than those who had not used either 197 
of the products.    198 
2.2. Design and Method 199 
The data were collected from consenting participants through a pen and paper 200 
questionnaire.  The majority of the questionnaire contained quantitative items, 201 
typically using a 7-point Likert-type scale.  In the case of a participant completing 202 
items relating to both products, the order of presentation of the items for each product 203 
was counterbalanced.  Analyses confirmed that the order of the presentation of the 204 
health products did not have a significant effect on the predictor or outcome measures 205 
for participants completing both sets of items. At the completion of the study, 206 
participants were provided with either subject credit (students) or were entered into a 207 
CD voucher draw (general public). 208 
2.3 Measures  209 
All questions about the participants’ future use of the health products asked 210 
participants to consider their willingness to consent to a free trial of the health 211 
products which involved consuming the product every day over the next 2 months.  212 
The specific terms of frequency of the behaviours was based on general usage 213 
recommendations and usage statistics (FSANZ, 2005).  The TPB measures were 214 
constructed based on guidelines according to Ajzen (2002).  As some items were 215 
presented in reversed forms, these were later re-scored and composite scores were 216 
created so that higher scores equated to stronger levels of the construct.  The examples 217 
provided below are for vitamin supplements but similar items were used for 218 
functional foods. 219 
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Given the participants lack of exposure and experience with these products, it 220 
was determined that non-users were unlikely to understand or identify with specific 221 
descriptions and that a broad outline of the applications of the health products would 222 
be most suitable for this initial investigation.  Participants were provided with the 223 
broad definitions for functional foods and vitamin supplements (see Figure 1).  224 
[Please insert Figure 1 about here] 225 
2.3.1 Previous adoption. To identify the non-users from a larger sample, a 226 
single item, based on items developed by Prochaska and DiClemente (1983, 1984), 227 
measured previous adoption.  Participants were asked to consider their use of the 228 
health product and select one option that best described their current use and ideas 229 
about future use; examples of the items used for vitamin supplements are given here.  230 
Participants who indicated that they were not currently using the health products were 231 
considered non-users if they answered positively to either of the statements: I 232 
currently do not take vitamin supplements and am not thinking about starting or I 233 
currently do not take vitamin supplements but I am thinking about starting.   234 
2.3.2 Attitude. A composite measure of attitudes towards each of the health 235 
products was created from four 7-point scales measuring how unpleasant/ pleasant; 236 
bad/ good; ineffective/ effective; and unfavourable/ favourable it was to trial each 237 
product.  Two of the scales, bad/ good and ineffective/ effective, were presented in 238 
reverse order.   239 
2.3.3 Subjective norm. A measure for subjective norm was derived from a 240 
composite of two items. Participants responded to two statements using a 7-point 241 
scale from 1 (strongly disagree) to 7 (strongly agree).  The statements were “Most 242 
people who are important to me would approve of me taking a vitamin supplement 243 
 11
everyday for the next 2 months” and “Those people who are important to me would 244 
want me to take a vitamin supplement every day for the next 2 months”.   245 
2.3.4 PBC.  Due to poor scale reliability for PBC measures for vitamin 246 
supplements (α = .099) and functional foods (α = .121), a single self efficacy measure 247 
was used.  Participants responded to the statement “I am confident that I could take a 248 
vitamin supplement every day for the next 2 months” using a 7-point scale from 1 249 
(strongly disagree) to 7 (strongly agree).  The analyses were also run using the 250 
control item “I have complete control over whether I take vitamin supplements every 251 
day for the next 2 months” using the same response scale and the same pattern of 252 
results was found. 253 
2.3.5 Risk dread. A pilot study (N = 19) was conducted using a short 254 
questionnaire which asked participants to list risks associated with vitamin 255 
supplements and functional foods.  The risks used in the current study were those 256 
most commonly identified by participants in the pilot study were: overdose (vitamin 257 
supplements) and eating something that has been scientifically altered (functional 258 
foods). 259 
Dread of risks was measured using a composite score of four items adapted 260 
from scales used by Fischhoff et al. (1978).  Participants were asked to consider the 261 
relevant risk related to the use of the health product and respond to four statements 262 
using a 7-point Likert scale from 1 (strongly disagree) to 7 (strongly agree).  The 263 
statements used for each product were “I cannot think about this risk without getting 264 
very worried about it.”, “I dread the effects of the risk a lot.”, “The risk is one that I 265 
can think very calmly about.”, and “I am not worried by this risk at all.”.  266 
2.3.6 Risk familiarity. Risk familiarity was measured using a composite score 267 
of four items adapted from scales used by Fischhoff et al. (1978). Participants rated 268 
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their familiarity with a specific potential risk for each health product. Using a 7-point 269 
scale from 1 (strongly disagree) to 7 (strongly agree) participants responded to the 270 
statements “Although the product may be new, the risk is one that I am very familiar 271 
with.”, “I know a lot about this risk.”, “In my mind, this is a completely new risk.”, 272 
and “I am not familiar with this risk at all.”.    273 
2.3.7 Willingness. The outcome measure, willingness, was adopted from the 274 
Prototype/ Willingness Model (Gibbons et al., 1998).  To assess openness to a trial 275 
session, a composite of two items was used to measure willingness to use the health 276 
products.  Participants were asked to consider the following situation: “At a 277 
supermarket you pass a table offering a free 2 month trial of vitamin supplements.  278 
You are offered one of the trial packs.  How willing would you be to try the free 279 
vitamin supplement trial for 2 months?”.  An additional reverse-scored item was also 280 
used “In the same situation, how willing would you be to say “No thanks” and not try 281 
the free vitamin supplement?”.  The response format was on a 7-point scale from 1 282 
(very willing) to 7 (not very willing). 283 
3. Results 284 
The data were screened for entry error, assumption of regression breaches, and 285 
univariate and multivariate outliers.  All scales were found to be reliable with 286 
Cronbach alphas over .68 or significant correlations for the two item scales.  The 287 
descriptive statistics for each health product, the Cronbach alphas for each scale, and 288 
bivariate correlation matrices for each variable are presented in Tables 2 and 3.  There 289 
were no overly high correlations (e.g., > .80).  For vitamin supplements, the strongest 290 
correlations were between attitude and subjective norm (.484, p < .001) and PBC and 291 
risk dread (-.232, p < .001); the weakest correlations for vitamin supplements were 292 
between subjective norm and PBC (-.011) and risk familiarity and willingness (-.001).  293 
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For functional foods the strongest correlations were found between attitude and 294 
subjective norm (.522, p < .001) and attitude and willingness (.413, p < .001); the 295 
weakest correlations for functional foods were between risk familiarity and PBC 296 
(.027), and risk familiarity and subjective norm (.045). 297 
[Please insert Tables 2 and 3 about here] 298 
3.2 Hypothesis testing 299 
To examine the determinants of non users’ willingness to try a free sample of 300 
vitamin supplements or functional foods, two regressions were conducted. As the 301 
demographic variables of age and gender were not found to be significant predictors 302 
of people’s willingness to use vitamin supplements or functional foods and their 303 
inclusion did not alter the final results of these analyses, these variables were 304 
excluded from the following analyses. 305 
3.2.1 Vitamin supplements.  A hierarchical linear regression analysis was used 306 
to examine the effect of the TPB constructs (attitudes, subjective norm, and PBC), 307 
dread of risks, and risk familiarity on people’s willingness to take part in a free trial of 308 
vitamin supplements every day for 2 months.   The first step of the regression, 309 
comprising the TPB factors of attitude, subjective norm, and PBC, was significant, R2 310 
= .297, F (3, 157) = 22.087, p < .001.  The second step, comprising dread of risk and 311 
familiarity of risk, was not significant, ∆R2 = .000, ∆F (2, 155) = 13.107, p < .958.  312 
The overall model significantly predicted willingness to engage in a free trial of 313 
vitamin supplements every day for the next 2 months, R2 = .297, F (5, 155) = 13.107, 314 
p < .001.  The significant predictors of willingness were attitude and subjective norms 315 
(see Table 4). 316 
[Please insert Table 4 about here] 317 
 14
3.2.2 Functional foods.  A hierarchical linear regression analysis was used to 318 
examine the effect of the TPB constructs (attitudes, subjective norm, and PBC), dread 319 
of risks, and risk familiarity on non-users’ willingness to take part in a free trial of 320 
functional foods every day for the next 2 months.  The first step of the regression, 321 
comprising the TPB factors of attitude, subjective norm, and PBC, was significant, R2 322 
= .217, F (3, 219) = 20.129, p < .001.  The second step, comprising dread of risk and 323 
familiarity of risk, was also significant, ∆R2 = .037, ∆F (2, 217) =5.333, p < .005.  The 324 
overall model significantly predicted non-users’ willingness to engage in a free trial of 325 
functional foods every day for the next 2 months, R2 = .253, F (5, 217) = 14.728, p < 326 
.001.  The significant predictors of willingness were attitude, subjective norms, and 327 
dread of risk (see Table 5). 328 
[Please insert Table 5 about here] 329 
4. Discussion 330 
The primary aim of the present study was to contribute to the current 331 
knowledge about people who are not currently using health products.  The study 332 
explored the determinants of non-users’ willingness to accept a free trial of vitamin 333 
supplements or functional foods.  Overall, this study provided strong support for the 334 
TPB constructs of attitude and subjective norm, but not PBC.  Of the additional risk 335 
factors examined, dread of risks was found to be a predictor of the non-users’ 336 
willingness to engage in a free trial of functional foods.  337 
From the TPB model, attitude and subjective norm were significant predictors 338 
of non-users’ willingness to use each of the health products examined.  These results 339 
support the underlying predictions of the TPB that positive evaluations of the 340 
behaviour and perceived pressure to perform a behaviour increases the likelihood that 341 
an individual will be willing to engage in that behaviour.  In part, this finding 342 
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corroborates similar results of studies of intentions to engage in other health 343 
behaviours (Astrom & Rise, 2001; Guardia et al., 2006) but contradicts the findings of 344 
previous Australian studies which found that attitude, but not subjective norms, is a 345 
significant determinant of the intentions of a sample of Australians to consumer foods 346 
enriched with Omega-3 fatty acids (Patch et al., 2005).  347 
PBC was not a significant predictor of willingness to trial either of the health 348 
products.  This result may be partly accounted for by the high mean and low 349 
variability for the PBC measure reflecting consumers’ high levels in confidence to 350 
control their behavior. Although non-significant, the results for willingness for both 351 
health products are also in the negative direction, indicating a desire by the non-users 352 
to avoid these products if they can control use.  A similar negative relationship has 353 
been documented between consumers’ beliefs that genetically modified (GM) foods 354 
should be clearly identified through product labelling, as a factor influencing one’s 355 
control over purchasing choices, and intention to use GM foods (O’Fallon, Gursoy, & 356 
Swanger, 2007).  In this study, people who strongly intended to purchase GM foods 357 
were more likely to believe that labelling about GM content was unnecessary than 358 
those who intended to avoid GM foods.  Further investigations into the nature of PBC, 359 
which include measures of self efficacy and perceived controllability, and factors 360 
influencing consumer control over purchase and consumption behaviours are required 361 
to explore this finding further.  362 
Of the additional risk predictors examined, risk dread was a significant 363 
negative predictor of non-users’ willingness to trial functional foods, but not to trial 364 
vitamin supplements.  As expected, lower risk dread was associated with greater 365 
likelihood of people’s willingness to consume functional foods.  These results indicate 366 
that risk dread influences non-users’ willingness to use functional foods but not 367 
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vitamin supplements. This result may be because participants did not see the risk of 368 
overdose as particularly catastrophic (Slovic, 1987).  Risk familiarity was a not a 369 
significant positive predictor of people’s willingness to trial either health product.  370 
This finding may be because non-users did not consider their level of familiarity 371 
important when making decisions about vitamin supplements and functional foods or 372 
that participant ratings of familiarity were based on awareness of the product, rather 373 
than a sound understanding of the technology or science behind the products.  Some 374 
studies have reported that awareness of functional foods in the general community is 375 
high, even if people do not understand the technologies behind functional foods (e.g., 376 
Urala & Lähteenmäki, 2004).  377 
Despite the strengths of this study, such as utilising an established theoretical 378 
framework, and comparing similar forms of health products, a number of limitations 379 
should be considered.  The method of measuring risk in this study was based on a 380 
previous program of research which examined a range of science or technology-based 381 
products (including food additives and colorings) and people’s reactions to these 382 
products. A limitation of this method is that, for each health behaviour, the 383 
participants were asked to consider one specific risk only.  This measurement limits 384 
the scope of this construct. Although this study demonstrated that risk dread is a valid 385 
determinant of people’s willingness to try functional food samples, a more global 386 
measure of risk dread, without reference to a single specific risk should also be 387 
considered. Exploring non-users’ willingness to trial vitamin supplements and 388 
functional foods using a variety of risk perception measurements may reveal more 389 
about the role of risk in people’s decision making; for example, a risk-benefit analysis  390 
may capture more of the variance related to consumers’ risk perceptions.  Other 391 
methods of measuring risk that may contribute to the prediction of functional food use 392 
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include measures of how risk-adverse consumers are (Weber, Blais, & Betz, 2002), 393 
and, from the Prototype Willingness Model (Gibbons et al., 1998), consumer 394 
perceptions of the typical person who would engage in functional food consumption 395 
and how favourable that prototype is perceived to be.  396 
As the study involved non-users of the health products, broad descriptions 397 
were used for functional foods and vitamin supplements, rather than highly detailed 398 
examples of specific health applications.  The TPB is designed for specific behaviours 399 
and these broad descriptions may have reduced the potential for the model to predict 400 
people’s willingness.  Further research into non-users reactions to specific product 401 
descriptions (e.g., omega 3 enriched eggs) would provide more information about 402 
particular products and potentially improve the proportions of variance explained. 403 
Using a single item of self efficacy to measure PBC is also a limitation, potentially 404 
impacting on the reliability of the findings for this construct. Where scale reliability 405 
allows, PBC should be measured using items representing both self efficacy and 406 
perceived controllability.  The measure for willingness may also be improved by 407 
altering the negative end of the scale from “not very willing” to “not at all willing”.  408 
This alteration would provide a clear indication of a person’s absence of willingness 409 
to trial an unfamiliar product. Also, in this study females were over-represented, 410 
future research should address this limitation by ensuring approximately equal 411 
numbers of males and females are recruited. Finally, future research should examine 412 
other comparable health products, for example, comparing vitamin supplements with 413 
pharmaceutical products.     414 
This study has theoretical implications for the TPB model.  Overall, the TPB 415 
did account for a substantial proportion of variance when entered into the regression 416 
analysis for each health product.  The results support attitude and subjective norms, 417 
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but not PBC, as predictors of willingness to trial health products.  Alone, these 418 
constructs predicted 30% and 22% of the variance in willingness to trial vitamin 419 
supplements and functional foods, respectively; however, control was not as 420 
important.  After accounting for the TPB constructs, adding a consideration of risk 421 
slightly improved the prediction of non-users willingness to trial functional foods.   422 
These results suggest that, when predicting non-users willingness to trial unfamiliar 423 
health products, such as functional foods, the TPB may be strengthened by including 424 
considerations of people’s perceptions of other conceptualisations of risk. 425 
On a practical level, the results of this study contribute to knowledge about 426 
current non-users and extend previous research attributing non-use to lack or 427 
awareness or interest and affordability (e.g., Niva, 2006).  The results of this study 428 
also suggest that, to improve willingness to trial these products, health professionals 429 
can promote positive attitudes about functional foods by providing information about 430 
the benefits of these products.  Uptake of functional foods may also be encouraged by 431 
distributing messages of approval from important groups, such as friends and general 432 
practitioners.  For example, communication with the public about these health 433 
products could include messages of endorsement from representatives of medical 434 
practitioners or from groups perceived to be peers.  Additionally, providing 435 
information to decrease the dread of risks may increase willingness of non-users to try 436 
samples of functional foods.  For instance, information about the risks involved in 437 
innovative health product use should explain the possible risks of use (e.g., overdose 438 
or damage to health) and discuss the severity and likelihood of these risks. For 439 
example, in Australia, given that the maximum allowed fortification levels of 440 
nutrients for many functional foods are moderate when compared to the daily 441 
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recommended intake levels, the risk of ‘overdosing’ on minerals or nutrients through 442 
most fortified foods is very low (e.g., FSANZ, 2009).  443 
Overall, this study provided support for the TPB variables of attitude and 444 
subjective norm in predicting non-users’ willingness to trial vitamin supplements and 445 
functional foods and for risk dread in predicting non-users’ willingness to trial 446 
functional foods.  The implications for this research suggest that attitude and 447 
subjective norms are both consistent and significant determinants of forming non-448 
users’ willingness to use vitamin supplements and functional foods.  Additionally, the 449 
introduction of risk-based constructs may strengthen standard TPB models when a 450 
novel health product is being considered.  Given the potential improvements to dietary 451 
intake, it is important to continue this research to determine the predictors of decision 452 
making regarding health products, like vitamin supplements and functional foods, and 453 
also to establish how use may be appropriately encouraged in those initially resistant 454 
to health product use.  Health practitioners attempting to encourage appropriate use of 455 
similar health products should focus on attitude change methods (e.g., by highlighting 456 
the positive aspects of the product) and reinforcing normative support for the product 457 
(e.g., including supportive statements from relevant people, such as medical doctors). 458 
When communicating with the public regarding functional foods, health practitioners 459 
should also consider methods aimed at reducing the dread of the product. This 460 
approach may include explaining the likely outcomes of product use in terms of risks 461 
and benefits. Potential benefits for this research includes appropriate engagement of 462 
current non-users in health promoting products. 463 
464 
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Table 1 563 
Demographic data for combined participant group (N = 271) 564 
Marital status* 
 Married Single
Divorced/ 
Widowed 
N 75 176 16 
% 27.7 64.9 5.9 
Income (in AUD)^ N % 
 Less than $10,000  57 21 
 $10,000-$30,000 62 22.9 
 $30,000-$60,000 63 23.2 
 $60,000-$90,000 40 14.8 
 More than $90,000 33 12.2 
    
Main occupation by industry+ N % 
 Student (full time) 69 25.5 
 Sales and hospitality 56 20.7 
 Science and research 28 10.4 
 Administration 25 9.2 
 Business and management 21 8.8 
 Allied health 22 8.1 
 Education 14 5.2 
 Trade 7 2.6 
 Retired 6 2.2 
 Other 9 3.6 
Note: * 4 participants did not respond
^16 participants did not respond 
+ 9 participants did not respond 
 565 
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 1 
Table 2  2 
Descriptive data for measures for vitamin supplements  3 
Variable M SD N 1. 2. 3. 4. 5. 6. 7. 8. 
1. Age 27.86 12.71 161         
2. Gender 1.43 .50 162 -.005        
3. Attitude 4.35 1.30 161 -.120 -.034 (.795)      
4. Subjective norm 4.22 1.42 162 -.085 .072 .484*** (.495***)     
5. PBC 6.33 1.15 162 .214** -.120 .056 -.011 -    
6. Risk dread 2.90 1.18 162 -.143 .104 -.153 -.044 -.232** (.688)   
7. Risk familiarity 3.99 1.41 162 -.173* .040 .117 -.070 .038 -.193* (.765)  
8. Willingness 3.57 1.81 162 -.073 -.096 -.204** .377** -.086 -.036 -.001 (.609***) 
Note. Mean scores in the current study are based on 7-point scales (1 to 7) Reliabilities reported in the diagonal. Where a construct was 4 
measured with two items, Pearson’s r (and significance) is reported.  5 
PBC = Perceived behavioural control. Gender is coded 1 (female) to 2 (male). 6 
*p < .05, ** p < .01, *** p < .001  7 
 8 
9 
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Table 3 1 
Descriptive data for measures for functional foods  2 
Variable M SD N 1. 2. 3. 4. 5. 6. 7. 8. 
1. Age 28.28 11.79 225         
2. Gender 1.36 .482 226 -.085        
3. Attitude 4.44 1.24 224 .013 -.072 (.851)      
4. Subjective norm 4.07 1.24 225 -.029 .056 .522*** (.448***)     
5. PBC 5.86 1.43 225 .079 -.141* -.055 .079 -    
6. Risk dread 3.44 1.23 225 .018 -.041 -.189** -.133* -.134* (.761)   
7. Risk familiarity 4.63 1.27 226 -.015 .050 .074 .045 .027 -.211** (.790)  
8. Willingness 3.75 1.68 225 -.097 .001 .413*** .388*** -.068 -.234*** .148* (.567***) 
Note. Mean scores in the current study are based on 7-point scales (1 to 7); Reliabilities reported in the diagonal. Where a construct was 3 
measured with two items, Pearson’s r (and significance) is reported.  4 
PBC = Perceived behavioural control. Gender is coded 1 (female) to 2 (male). 5 
*p < .05, ** p < .01, *** p < .00 6 
 7 
8 
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Table 4 1 
Hierarchical multiple regression analysis predicting willingness to trial vitamin supplements 2 
Step Variable B SE β 
1     
 Attitude .612 .106 .440*** 
 Subjective norm .207 .097 .164* 
 PBC -.111 .105 -.070 
2     
 Attitude .613 .108 .441*** 
 Subjective norm .209 .097 .165* 
 PBC -.107 .109 -.068 
 Risk dread .020 .109 .013 
 Risk familiarity .023 .088 .018 
Note. R² = .30 for step 1; R² = .30 for step 2.  
PBC = Perceived behavioural control. 
ŧ p <.07, * p < .05, ** p < .01, *** p < .001 
3 
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Table 5 1 
Hierarchical multiple regression analysis predicting willingness to trial functional foods 2 
Step Variable B SE β 
1     
 Attitude .375 .095 .279*** 
 Subjective norm .335 .095 .248** 
 PBC -.084 .071 -.072 
2     
 Attitude .329 .094 .245** 
 Subjective norm .330 .094 .244** 
 PBC -.112 .070 -.096 
 Risk dread -.195 .084 -.143* 
 Risk familiarity .141 .080 .107 
Note. R² = .22 for step 1; R² = .25 for step 2.  
PBC = Perceived behavioural control.  
ŧ p <.07, * p < .05, ** p < .01, *** p < .001 
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Definition for Functional foods: 1 
 “Functional foods have been altered to provide an additional health benefit.  2 
In this study, the term ‘functional foods’ does NOT include those foods altered 3 
through genetic modification.  An example of a functional food is A2 Milk.  A2 Milk is 4 
milk in which the content of a natural variant of the protein beta casein A2 (A2) has 5 
been increased on the basis that the A2 protein may be linked with reduced heart 6 
disease.  Other functional foods can include fruits and vegetables, cereals, 7 
margarines and processed goods made from these foods”  8 
Definition for vitamin supplements: “A vitamin is a chemical that your body 9 
uses to execute basic functions. The human body is unable to create all vitamins itself 10 
and relies on vitamins provided through food and drink.  The body can only absorb 11 
and use a certain amount of each type of vitamin molecules each day.  Vitamin 12 
supplements contain a prepared combination of vitamins that people may ingest”.   13 
 14 
Figure 1: Definition for Functional Foods and Vitamin Supplements 15 
 16 
